Lansoprazole Capsule, Delayed Release
Product Images NDC 63187-152

4 FDA label images from Proficient Rx Lp · Packaging, Regulatory Labels, and Product Appearance

Product Visual Gallery

This gallery contains 4 technical images submitted to the FDA as part of the official labeling for Lansoprazole (NDC 63187-152). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.

As provided by Proficient Rx Lp, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.

FDA Label Image

Lansoprazole Structural Formula (B944787d 4dc0 4086 A5aa E5beafa6e37d 01)

Lansoprazole Structural Formula (B944787d 4dc0 4086 A5aa E5beafa6e37d 01)
Chemical structure of lansoprazole showing its molecular arrangement with sulfoxide, pyridine, and benzimidazole rings along with substituent groups, as related to the active ingredient in Lansoprazole 30 mg delayed-release capsules by Proficient Rx LP.*
FDA Label Image

Figure 1 (B944787d 4dc0 4086 A5aa E5beafa6e37d 02)

Figure 1 (B944787d 4dc0 4086 A5aa E5beafa6e37d 02)
A line graph showing mean severity of day heartburn over 60 days from the start of treatment, comparing placebo, Lansoprazole 15 mg once daily, and Lansoprazole 30 mg once daily. The graph illustrates decreased heartburn severity with Lansoprazole treatments compared to placebo over time.*
FDA Label Image

Figure 2 (B944787d 4dc0 4086 A5aa E5beafa6e37d 03)

Figure 2 (B944787d 4dc0 4086 A5aa E5beafa6e37d 03)
A line graph showing mean severity of night heartburn over days from start of treatment. The graph compares three groups: placebo, lansoprazole 15 mg once daily, and lansoprazole 30 mg once daily. Severity decreases over time for both lansoprazole groups compared to placebo.*
FDA Label Image

Lansoprazole 30mg (B944787d 4dc0 4086 A5aa E5beafa6e37d 04)

Lansoprazole 30mg (B944787d 4dc0 4086 A5aa E5beafa6e37d 04)
Label for Lansoprazole 30 mg delayed-release capsules by Proficient Rx LP. The label states each capsule contains 30 mg of lansoprazole USP as enteric-coated granules and describes the physical appearance of the hard gelatin capsules. The product ID RL015230 and manufacturer Teva Pharmaceutical Industries LTD Jerusalem, Israel, are noted. Storage instructions and child safety warnings are included. Multiple smaller repeated labels are visible on the right side.*

* About these descriptions: Image descriptions on this page are generated by automated AI analysis of the product label images from the manufacturer's FDA label submission (SPL). They are provided for reference only and may contain errors or omissions. Always rely on the printed label itself and the official FDA labeling, and consult a pharmacist or healthcare professional with any questions about this product.